Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study

Journal of the Royal Society of Medicine

Volumn 109, Issue 8, 2016, Pages 303-309

  Seminog, Olena O ^a   Ogunlaja, Oyindamola I ^a   Yeates, David ^a   Goldacre, Michael J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

cancer risk; epidemiology; haematological malignancies; record linkage studies; Sickle cell disease

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLACK PERSON; CANCER INCIDENCE; CANCER RISK; CAUCASIAN; CHILD; CLINICAL STUDY; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENGLAND; ETHNIC DIFFERENCE; ETHNICITY; FACE VALIDITY; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HOSPITAL ADMISSION; HUMAN; INFANT; KIDNEY CANCER; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTIPLE MYELOMA; MYELOID LEUKEMIA; NON MELANOMA SKIN CANCER; NONHODGKIN LYMPHOMA; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SICKLE CELL ANEMIA; SOLID TUMOR; STATISTICAL ANALYSIS; THYROID CANCER; CASE CONTROL STUDY; COMPLICATION; FACTUAL DATABASE; MIDDLE AGED; NEOPLASMS; NEWBORN; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; ENGLAND; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84982965353     PISSN: 01410768     EISSN: 17581095     Source Type: Journal    
DOI: 10.1177/0141076816651037     Document Type: Article

References (29)

1. D.C.ReesT.N.WilliamsM.T.Gladwin. Sickle-cell disease. Lancet2010; 2376: 2018–2031.
2. National Health Service. NHS choicesBristol, UK: IOP PublishingSee http://www.nhs.uk/conditions/Sickle-cell-anaemia/Pages/Introduction.aspx (last checked 4 September 2015).
3. R.B.StrickerC.A.LinkerT.J.CrowleyS.H.Embury. Haematological malignancy in sickle cell disease: report of four cases and review of the literature. Am J Hematol1986; 21: 223–230.
4. H.S.KimL.YospurY.Niihara. Chronic lymphocytic leukemia in a patient with sickle cell anaemia. West J Med1998; 169: 114–116.
5. S.Paydas. Sickle cell anaemia and haematological neoplasias. Leuk Lymphoma2002; 43: 1431–1434.
6. B.BrownT.R.Kotila. Hodgkin lymphoma in a child with sickle cell anaemia. Pediatr Hematol Oncol2007; 24: 531–532.
7. L.ChenM.ZhuangH.Q.ShahH.L.Jen. Chronic myelogenous leukemia in sickle cell anemia. Arch Pathol Lab Med2005; 129: 423–424.
8. W.H.SchultzR.E.Ware. Malignancy in patients with sickle cell disease. Am J Hematol2003; 74: 249–253.
9. F.W.DawkinsK.S.KimR.S.SquiresR.ChisholmJ.A.KarkE.Perlin. Cancer incidence rate and mortality rate in sickle cell disease patients at Howard University Hospital: 1986–1995. Am J Hematol1997; 55: 188–192.
10. M.J.GoldacreL.KurinaD.YeatesV.SeagroattL.Gill. Use of large medical database study associations between diseases. QJM2000; 93: 669–675.
11. M.J.GoldacreC.J.WottonV.SeagroattD.Yeates. Cancers and immune related diseases associated with Down’s syndrome: a record linkage study. Arch Dis Child2004; 89: 1014–1017.
12. M.TurnerR.GoldacreM.Goldacre. Reduced cancer incidence in Huntington’s disease: record linkage study clue to an evolutionary trade-off?Clin Genet2013; 83: 588–590.
13. O.O.SeminogM.J.Goldacre. Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer2014; 108: 193–198.
14. C.L.SaundersG.A.AbelA.El TurabiF.AhmedG.Lyratzopoulos. Accuracy of routinely recorded ethnic group information compared with self-reported ethnicity: evidence from the English Cancer Patients Experience Survey. BMJ Open2013; 28: 3, DOI: 10.1136/bmjopen-2013-002882.
15. N.E.BreslowN.E.DayStatistical methods in cancer research. In: (eds). The Design and Analysis of Cohort Studies, Lyon: International Agency for Research in Cancer, 1987, pp. 103–115.
16. National Cancer Intelligence Network and Cancer Research. Cancer incidence and survival by major ethnic group, England, 2002–2006. See http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDkQFjAA&url=http%3A%2F%2Fwww.ncin.org.uk%2Fview%3Frid%3D75&ei=ERy_UeKQF4jCPIGMgKAG&usg=AFQjCNGwcQ8VLlvNpS8WBwlm5_cftE271w&sig2=EC0J7BsH8-6jURiGziGs5g&bvm=bv.47883778,d.ZWU (2010, last checked 4 September 2015)
17. L.SimpsonX.HeM.PinsX.HuangS.C.CampbellX.J.Yang. Renal medullary carcinoma and ABL gene amplification. J Urol2005; 173: 1883–1888.
18. W.G.Noguera-IrizarryH.HibshooshK.P.Papadopoulos. Renal medullary carcinoma: case report and review of the literature. Am J Clin Oncol2003; 26: 489–489.
19. B.MuzP.De La PuenteF.AzabM.LudererA.K.Azab. The role of hypoxia and exploitation of the hypoxic environment in hematologic malignancies. Mol Cancer Res2014; 12: 1347–1354.
20. R.P.HebbelR.OsarogiagbonD.Kaul. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation2004; 11: 129–151.
21. A.MakisE.HatzimichaelK.Bourantas. The role of cytokines in sickle cell disease. Ann Hematol2000; 79: 407–413.
22. A.SoloveyL.GuiS.RamakrishnanM.H.SteinbergR.P.Hebbel. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood1999; 93: 3824–3830.
23. A.J.MajmundarW.J.WongM.C.Simon. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell2010; 40: 294–309.
24. F.BaronM.F.DresseY.Beguin. Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation. N Engl J Med2003; 349: 913–914.
25. E.C.VamvakasM.A.Blajchman. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?Blood2001; 97: 1180–1195.
26. M.H.SteinbergW.F.McCarthyO.CastroS.K.BallasF.D.ArmstrongW.Smith. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. Am J Hematol2010; 85: 403–408.
27. P.T.McGannJ.M.FlanaganT.A.HowardS.D.DertingerJ.HeA.S.Kulharya. Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG phase III clinical trial. Pediatr Blood Cancer2012; 2: 254–257.
28. H.MøllerS.RichardsN.HanchettS.P.RiazM.LüchtenborgL.Holmberg. Completeness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates. Br J Cancer2011; 105: 70–176.
29. Foster M. National Haemoglobinopathy Registry Report 2013/14. See http://r.search.yahoo.com/_ylt=A0LEViMCoQJX1ogA1jAnnIlQ;_ylu=X3oDMTByOHZyb21tBGNvbG8DYmYxBHBvcwMxBHZ0aWQDBHNlYwNzcg–/RV=2/RE=1459818883/RO=10/RU=http%3a%2f%2fwww.nhr.nhs.uk%2fwp-content%2fuploads%2f2015%2f10%2fNHR_AnnualReport_2014.pdf/RK=0/RS=cFZHE7d8egA7WHzjWEkE.Fl3f9g- (2014, last checked 17 May 2016)